Rallis India

The uptick in Rallis India share price came after the company announced a healthy set of September quarter of financial year 2025 (Q2FY25) results on Tuesday, October 15.

Rallis India, a subsidiary of Tata Chemicals, on Tuesday reported a 19.51 per cent growth in net profit during the quarter ending September 30 to Rs 98 crore compared to the same period in the previous financial year. The company's net profit stood at Rs 82 crore during the corresponding quarter of the previous fiscal year, Rallis India said in a regulatory filing. Revenue from operations of the company witnessed an 11.53 per cent growth during the second quarter of the current fiscal year at Rs 928 crore compared to Rs 832 crore a year ago. "We had a strong second quarter performance in FY25, helped by double-digit growth in the domestic market, both in the Crop Care and Seeds business. Revenue increased to reach Rs 928 crore and profit after tax increased to reach Rs 98 crore," Rallis India Managing Director and CEO Dr Gyanendra Shukla said. "International business had volume recovery though prices continue to be a challenge. We remain positive for the upcoming rabi season with .

Analysts at Elara Capital remain bullish on the Rallis' crop care division prospects, driven by the robust outlook on the domestic business and cautiously optimistic outlook on the international biz.

The agrochemical firm reported a 23.80 per cent year-on-year (YoY) decline in profit after tax (PAT) to Rs 48 crore for the quarter ending June 30, compared to Rs 63 crore in the same period

Rallis India, a subsidiary of Tata Chemicals, on Thursday reported a 23.80 per cent decline in profit after tax at Rs 48 crore during the quarter ending June 30, compared to the same period in the previous financial year. The company's PAT stood at Rs 63 crore during the corresponding quarter of the previous fiscal, Rallis India said in a regulatory filing. Revenue from operations of the company was flat at Rs 783 crores during the quarter under review compared to Rs 782 crores during the same period of the previous year. Crop care business delivered strong volume-led revenue growth of 8 per cent. Seeds revenue was down by 16 per cent largely due to supply constraints. Despite market challenges, concerted actions were taken to drive margins through better product mix and dynamic pricing, Rallis India Managing Director and CEO Dr Gyanendra Shukla said. "We remain cautious about the export market and expect a gradual recovery during the year. Sentiments for the domestic market are ..

The company's portfolio of Crop Protection, Crop Nutrition and Improved Seeds supported by wide market reach, aims to address the emerging needs of the Indian farming community

Rallis India said that its board has appointed Gyanendra Shukla as managing director (MD) & chief executive officer (CEO) of the company for a period of 5 years with effect from 1 April 2024

Tata group firm Rallis India on Wednesday reported a 13.88 per cent growth in profit after tax (PAT) for the quarter ending September 30 to Rs 82 crore compared to the same period of the previous financial year. The company posted a PAT of Rs 72 crore for the corresponding period of the previous fiscal, Rallis India said in a regulatory filing. However, revenue from operations of the company declined by 12.51 per cent during the quarter under review at Rs 832 crore compared to Rs 951 crore in the same period of the previous year. Our revenue has been affected by weak export demand, falling prices and erratic rainfall in the domestic market. "Although our revenue for the second quarter of FY24 was lower at Rs 832 crores compared to Rs 951 crores of the same period of the previous year, margins have improved through better product mix and cost optimisation activities across businesses," Rallis India Managing Director and CEO Sanjiv Lal said. He said the company's crop care revenue w

Tata Chemicals acquired 9.7 million shares of its subsidiary for Rs 208 crore through a bulk deal, with face value of Re 1 each at Rs 215.05 per equity share.

Stocks to watch on July 19, 2023: From Paytm to Piramal Pharma, here are the top stocks to watch in Wednesday's trading session

Tata Chemicals on Tuesday said it has acquired 97 lakh shares of its subsidiary Rallis India for Rs 208 crore through a block deal, increasing its stake by 5 per cent to 55.04 per cent. In a regulatory filing, Tata Chemicals said the company acquired 97 lakh equity shares of Rallis India, with face value of Re 1 each, at Rs 215.05 per equity share. This represented 4.99 per cent of the paid-up share capital of Rallis. Agri inputs firm Rallis is into manufacturing, distribution, sales and marketing of crop protection and crop nutrition products, and a variety of field crop and seeds. Recently, Rallis reported a marginal fall in net profit at Rs 63 crore for June quarter as against Rs 67 crore in the year-ago period. Total income fell to Rs 765 crore in April-June of this financial year from Rs 867 crore in the corresponding period of the previous year.

Rallis India, a subsidiary of Tata Chemicals, on Tuesday reported a loss of Rs 69.13 crore during the quarter ending March 31. The company had reported a loss of Rs 14.13 crore during the corresponding quarter of 2021-22, Rallis India said in a regulatory filing. Revenue from operations of the company witnessed a growth of 2.97 per cent during the quarter under review at Rs 522.62 crore compared to Rs 507.54 crore in the same period of the previous fiscal. For the entire fiscal year 2022-23, the company witnessed a 45.68 per cent decline in net profit at Rs 91.94 crore compared to Rs 164.27 crore in FY22. Revenue from operations of the company grew by 13.94 per cent to Rs 2,966.97 crore in FY23, compared to Rs 2,603.93 crore in 2021-22. "The company delivered 14 per cent revenue growth over the previous year despite multiple headwinds. Our domestic crop care business grew by 12 per cent and exports by 25 per cent during the year. Exports recorded a revenue of Rs 979 crore in FY23,

The BJP is set to launch its campaign for the Tripura assembly elections with 35 rallies on Friday

The decision to stay with these stocks, analysts said, should be based purely on how each of these companies is performing fundamentally

Titan and Escorts look promising on the charts, while Star Health and Allied Insurance, Nazara Technologies and Rallis India need to conquer major hurdles for further gains, technical charts suggest.

Stocks to Watch Today: CEAT, Havells, IndusInd Bank, Mastek, OFSS, RIIL, Syngene International, Tata Communications and Wirpo to announce Q1 results on Wednesday.

Exporters could do better as domestic firms are hit by monsoon delay, inventories

The company posted losses at the operating level in Q4FY22

The stock tanked 9.69 per cent to settle at Rs 253.85 on the BSE. During the day, it tumbled 10.28 per cent to Rs 252.20

The company reported a consolidated net loss of Rs 14 crore in March quarter on higher raw material cost.